FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046504744> ?p ?o ?g. }

• W2046504744 endingPage "712" @default.
• W2046504744 startingPage "697" @default.
• W2046504744 abstract "Annals of the New York Academy of SciencesVolume 685, Issue 1 p. 697-712 Gene Transfer for Therapy and Prophylaxis of HIV-1 Infection MARK L. ROHRBAUGH, MARK L. ROHRBAUGH Division of Extramural Activities National Institute of Allergy and Infectious Diseases National Institutes of Health Bethesda, Maryland 20892Search for more papers by this authorJOHN J. McGOWAN, JOHN J. McGOWAN Division of Extramural Activities National Institute of Allergy and Infectious Diseases National Institutes of Health Bethesda, Maryland 20892Search for more papers by this author MARK L. ROHRBAUGH, MARK L. ROHRBAUGH Division of Extramural Activities National Institute of Allergy and Infectious Diseases National Institutes of Health Bethesda, Maryland 20892Search for more papers by this authorJOHN J. McGOWAN, JOHN J. McGOWAN Division of Extramural Activities National Institute of Allergy and Infectious Diseases National Institutes of Health Bethesda, Maryland 20892Search for more papers by this author First published: June 1993 https://doi.org/10.1111/j.1749-6632.1993.tb35933.xCitations: 2AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Rosenberg, S. A., P. Aebersold, K. Cornetta, A. Kasid, R. A. Morgan, R. Moen, E. M. Karson, M. T. Lotze, J. C. Yang, et al. 1990. Gene transfer into humans—immunotherapy of patients with advanced melanoma using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. J. Med. 323: 570–578. 2 Blume, E. 1990. Gene therapy trial finally begins [news]. J. Natl. Cancer Inst. 82: 1601. 3 Anderson, W. F., R. M. Blaese & K. Culver. 1990. The ADA human gene therapy clinical protocol. Hum. Gene Ther. 1: 331–362. 4 Antoine, F. S. 1990. Human gene therapy trial in cancer patients about to begin [news]. J. Natl. Cancer Inst. 82: 1877–1878. 5 Waalen, J. 1992. Testing expands in gene therapy, gene transfer [news]. J. Natl. Cancer Inst. 84: 380–382. 6 Stone, R. 1992. Molecular “surgery” for brain tumors [news]. Science 256: 1513. 7 Jenks, S. 1992. Gene therapy for ADA takes next step [news]. J. Natl. Cancer Inst. 84: 382. 8 Thompson, T. 1992. At age 2, gene therapy enters a growth phase [news]. Science 258: 744–746. 9 Roemer, K. & T. Friedmann. 1992. Concepts and strategies for human gene therapy. Eur. J. Biochem. 208: 211–225. 10 Miller, A. D. 1992. Human gene therapy comes of age. Nature 357: 455–460. 11 Gutierrez, A. A., N. R. Lemoine & K. Sikora. 1992. Gene therapy for cancer. Lancet 339: 715–721. 12 J. D. Watson, M. Gilman, J. Witkovski & M. Zoller, Eds. 1992. Recombinant DNA, 2nd ed.: 567–581. Scientific American Books. New York . 13 Stewart, M. J., G. E. Plautz, L. Del Buono, Z. Y. Yang, L. Xu, X. Gao, L. Huang, E. G. Nabel & G. J. Nabel. 1992. Gene transfer in vivo with DNA liposome complexes: safety and acute toxicity in mice. Hum. Gene Ther. 3: 267–275. 14 Chang, J. M. & G. R. Johnson. 1989. Gene transfer into hematopoietic stem cells using retroviral vectors. Int. J. Cell Cloning 7: 264–280. 15 Miller, A. D. & G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. Biotechniques 7: 980–990. 16 Gilboa, E. 1990. Retrovirad gene transfer: applications to human therapy. Prog. Clin. Biol. Res. 352: 301–311. 17 Culver, K. W., Z. Ram, S. Wallbridge, H. Ishii, E. H. Oldfield & R. M. Blaese. 1992. In vivo gene transfer with retroviral vector-producing cells for treatment of experimental brain tumors. Science 256: 1550–1552. 18 Federoff, H. J., M. D. Geschwind, A. I. Geller & J. A. Kessler. 1992. Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia. Proc. Natl. Acad. Sci. USA 89: 1636–1640. 19 Fink, D. J., L. R. Sternberg, P. C. Weber, M. Mata, W. F. Goins & J. C. Glorioso. 1992. In vivo expression of β-galactosidase in hippocampal neurons by HSV-mediated gene transfer. Hum. Gene Ther. 3: 11–19. 20 Rosenfeld, M. A., K. Yoshimura, B. C. Trapnell, K. Yoneyama, E. R. Rosenthal, W. Dalemans, M. Fukayama, J. Bargon, L. E. Stier, L. Stratford-Perricaudet, M. Perricaudet, W. Guggino, A. Pavirani, J. P. Lecocq & R. G. Crystal. 1992. In vivo transfer of the human cystic fibrosis transmembrane conductive regulator gene to the airway epithelium. Cell 68: 143–155. 21 Russell, S. J., A. Brandenburger, C. L. Flemming, M. K. L. Collins & J. Rommelaere. 1992. Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus. J. Virol. 66: 2821–2828. 22 Cotmore, S. F. & P. Tattersall. 1987. The autonomously replicating parvoviruses of vertebrates. Adv. Virus Res. 33: 91–173. 23 Srtvastava, A., E. Bruno, R. Briddell, R. Cooper, C. Srtvastava, K. Van Besien & R. Hoffman. 1990. Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro. Blood 76: 1997–2004. 24 McLaughlin, S. K., P. Collis, P. L. Hermonat & N. Muzyczka. 1988. Adeno-associated virus general transduction vectors: analysis of proviral structures. J. Virol. 62: 1963–1973. 25 Samulski, R. J., X. Zhu, X. Xiao, J. D. Brook, D. E. Housman, N. Epstein & L. A. Hunter. 1991. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10: 3941–3950. 26 Zaia, J. A., S. Chatterjee, K. K. Wong, D. Elkins, N. R. Taylor & J. J. Rossi. 1992. Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy. Ann. N. Y. Acad. Sci. 660: 95–106. 27 Sarver, N., R. J. Black, S. Bridges & L. Chrisey. 1992. Frontiers in HIV-1 therapy: Fourth Conference of the NIAID National Cooperative Drug Discovery Groups—HIV. AIDS Res. Hum. Retroviruses 8: 659–667. 28 Ho, R. J. Y., B. T. Rouse & L. Huang. 1987. Target-sensitive immune liposomes as an efficient drug carrier for antiviral activity. J. Biol. Chem. 262: 13878–13973. 29 Marwick, C. 1992. As number of trials increases, gene therapy begins to look promising for medicine's future [news]. JAMA 267: 2854–2855. 30 Spangrude, G. J., S. Heinfeld & I. L. Weissman. 1988. Purification and characterization of mouse hematopoietic stem cells. Science 241: 58–62. 31 Cann, A. J. & J. Karn. 1989. Molecular biology of HIV: New insights into the virus life-cycle. AIDS 3 (Suppl. 1): S19–S34. 32 Stevenson, M., M. Bukrinsky & S. Haggerty. 1992. HIV-1 replication and potential targets for intervention. AIDS Res. Hum. Retroviruses 2: 107–117. 33 Herskowitz, I. 1987. Functional inactivation of genes by dominant negative mutations. Nature 329: 219–222. 34 Baltimore, D. 1988. Gene therapy: Intracellular immunization. Nature 335: 395–396. 35 Warner, J. F., C.-G. Anderson, L. Laube, D. J. Jolly, K. Townsend, S. Chada & D. St. Louis. 1991. Induction of HIV-specific CTL and antibody responses in mice using retroviral vector-transduced cells. AIDS Res. Hum. Retroviruses 7: 645–655. 36 Jenks, S. 1992. RAC approves gene protocol for adult twins with AIDS [news]. J. Natl. Cancer Inst. 84: 1468–1469. 37 Young, J. A., P. Bates, K. Willert & H. E. Varmus. 1990. Efficient incorporation of human CD4 protein into avian leukosis virus particles. Science 250: 1421–1423. 38 Shimada, T., F. Hiroyuki, H. Mitsuya & A. W. Nienhius. 1991. Targeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficiency virus retroviral vector. J. Clin. Inves. 88: 1043–1047. 39 Poznansky, M., A. Lever, L. Bergeron, W. Haseltine & J. Sodroski. 1991. Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector. J. Virol. 65: 532–536. 40 Buchschacher, G. L. & A. T. Panganiban. 1992. Human immunodeficiency virus vectors for inducible expression of foreign genes. J. Virol. 66: 2731–2739. 41 Harrison, G. S., F. Maxwell, C. J. Long, C. A. Rosen, L. M. Glode & I. H. Maxwell. 1991. Activation of a diphtheria toxin A gene by expression of human immunodeficiency virus-1 Tat and Rev proteins in transfected cells. Hum. Gene Ther. 2: 53–60. 42 Harrison, G. S., C. J. Long, F. Maxwell, L. M. Globe & I. H. Maxwell. 1992. Inhibition of HIV production in cells containing an integrated, HIV-regulated diphtheria toxin A chain gene. AIDS Res. Hum. Retroviruses 8: 39–45. 43 Sun, X.-H. & D. Baltimore. 1989. Human immunodeficiency virus tat-activated expression of poliovirus protein 2A inhibits mRNA translation. Proc. Natl. Acad. Sci. USA 86: 2143–2146. 44 Venkatesh, L. K., M. Q. Arens, T. Subramanian & G. Chinnadurai. 1990. Selective induction of toxicity to human cells expressing human immunodeficiency virus type 1 tat by a conditional cytotoxic adenovirus vector. Proc. Natl. Acad. Sci. USA 87: 8746–8750. 45 Mullen, C. A., M. Kilstrup & M. Blaese. 1992. Transfer of a bacterial gene for cystidine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system. Proc. Natl. Acad. Sci. USA 89: 33–37. 46 Feinberg, M. B. & D. Trono. 1992. Intracellular immunization: trans-dominant mutants of HIV gene products as tools for the study and interruption of viral replication. AIDS Res. Hum. Retroviruses 8: 1013–1022. 47 Freed, E. O., E. L. Delwart, G. L. Buschacher, Jr. & A. T. Panganiban. 1992. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc. Natl. Acad. Sci. USA 89: 70–74. 48 Malim, M. H., S. Böhnlein, J. Hauber & B. R. Cullen. 1989. Functional dissection of the HIV-1 Rev trans-activator: Derivation of a trans-dominant repressor of Rev function. Cell 58: 205–214. 49 Green, M., M. Ishino & P. M. Loewenstein. 1989. Mutational analysis of transdominant mutants that suppress HIV-LTR-driven gene expression. Cell 58: 215–223. 50 Trono, D., M. B. Feinberg & D. Baltimore. 1989. HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus. Cell 59: 113–120. 51 Morgan, R. A., D. J. Looney, D. D. Muenchau, F. Wong-Staal, R. C. Gallo & W. F. Anderson. 1990. Retroviral vectors expressing soluble CD4: a potential gene therapy for AIDS. AIDS Res. Hum. Retroviruses 6: 183–191. 52 Buonocore, L. & J. K. Rose. 1990. Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum. Nature 345: 625–628. 53 Izant, J. G. & H. Weintraub. 1984. Inhibition of thymidine kinase gene expression by antisense RNA: a molecular approach to genetic analysis. Cell 36: 1007–1015. 54 Van Der Krol, A. R., J. N. M. Mol & A. R. Stuttje. 1988. Modulation of eukaryotic gene expresison by complementary RNA or DNA sequences. Bio Techniques 6: 958–976. 55 Mirabelli, C. K., C. F. Bennett, K. Anderson & S. T. Crooke. 1991. In vitro and in vivo pharmacologic activities of antisense oligonucleotides. Anti-Cancer Drug Res. 6: 647–661. 56 Chang, L.-J. & C. M. Stoltzfus. 1987. Inhibition of Rous sarcoma virus replication by antisense RNA. J. Virol. 61: 921–924. 57 Gyotoku, J.-I., M. A. El-Farrash, S. Fujimoto, W. T. V. Germeraad, Y. Watanabe, K. Teshigawara, S. Hasada & Y. Katsura. 1991. Inhibition of human immunodeficiency virus replication in a human T cell line by antisense RNA expressed in the cell. Virus Genes 5: 189–202. 58 Sullenger, B. A., H. F. Gallardo, G. E. Ungers & E. Gilboa. 1990. Over-expression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 63: 601–608. 59 Sullenger, B. A., H. F. Gallardo, G. E. Ungers & E. Gilboa. 1991. Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation. J. Virol. 65: 6811–6816. 60 Lee, T. C., B. A. Sullenger, H. F. Gallardo, G. E. Ungers & E. Gilboa. 1992. Overexpression of RRE-derived sequences inhibits HIV-1 replication in CEM cells. New Biol. 4: 66–74. 61 Lo, K. M. S., M. A. Biasolo, G. Dehni, G. Palú & W. A. Haseltine. 1992. Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA. Virol. 190: 176–183. 62 Rossi, J. J., E. M. Cantin, N. Sarver & P. F. Chang. 1991. The potential use of catalytic RNAs in therapy of HIV infection and other diseases. Pharmac. Ther. 50: 245–254. 63 Sarver, N., E. Cantin, P. Chang, P. Ladne, D. Stephans, J. Zaia & J. J. Rossi. 1990. Ribozymes as potential anti-HIV therapeutic agents. Science 247: 1222–1224. 64 Weerasinghe, M., S. E. Liem, A. Sabah, S. E. Read & S. Joshi. 1991. Resistance to human immunodeficiency virus type 1 (HIV-1) infection in human CD4+ lymphocyte-derived cell lines conferred by using retroviral vectors expressing an HIV-1 RNA-specific ribozyme. J. Virol. 65: 5531–5534. 65 Chatterjee, S., P. R. Johnson & K. K. Wong, Jr. 1992. Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector. Science 258: 1485–1488. 66 Berzal-Herranz, A., S. Joseph & J. M. Burke. 1992. In vitro selection of active hairpin ribozymes by sequential RNA-catalyzed cleavage and ligation reactions. Genes Dev. 6: 129–134. 67 Schröder, H. C., R. J. Suhadolnik, W. Pfleiderer, R. Charubala & W. E. G. Müller. 1992. (2'-5') oligoadenylate and intracellular immunity against retrovirus infection. Int. J. Biochem. 24: 55–63. 68 Schröder, H. C., D. Ugarkovic, H. Merz, Y. Kuchino, T. Okamoto & W. E. Müller. 1990. Protection of HeLa-T4+ cells against human immunodeficiency virus (HIV) infection after stable transfection with HIV LTR-2', 5'-oligoadenylate synthetase hybrid gene. FASEB J. 4: 3124–3130. 69 Eager, K. B., C. J. Hackett, W. U. Gerhard, J. Bennink, L. C. Eisenlohr, J. Yewdell & R. P. Ricciandi. 1989. Murine cell lines stably expressing the influenza virus hemagglutinin gene introduced by a recombinant retrovirus vector are constitutive targets for MHC class I- and class II-restricted T lymphocytes. J. Immunol. 143: 2328–2335. 70 Wolff, J. A., R. W. Malone, P. Williams, W. Chang, G. Acsadi, A. Jani & P. L. Felgner. 1990. Direct gene transfer into mouse muscle in vivo. Science 247: 1465–1468. 71 Tang, D.-C., M. DeVit & S. A. Johnston. 1992. Genetic immunization is a simple method for eliciting an immune response. Nature 356: 152–154. 72 Robinson, H. L., L. A. Hunt & R. G. Webster. 1993. Protection against a lethal influenza virus challenge by immunization with a hemagglutinin-expressing plasmid DNA. Vaccine. In press. 73 Liu, M. A., J. B. Ulmer, A. Friedman, D. Martinez, L. A. Hawe, C. M. DeWitt, K. R. Leander, X.-P. Shi, S. Parker, P. Felgner, J. Felgner, D. L. Montgomery & J. J. Donnelly. 1993. Immunization with DNA encoding a conserved internal viral protein results in protection from morbidity and mortality due to challenge with influenza A in mice. In Vaccines '93: Modern Approaches to New Vaccines Including Prevention of AIDS. H. Ginsberg et al., Eds.: 343–346. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, New York . 74 Rhodes, G. H., A. M. Abai, V. J. Dwarki, S. E. Parker, M. Manthorpe, J. Felgner, P. L. Felgner & S. H. Gromkowski. 1993. A novel method of inducing cellular and humoral immunity to HIV gp 120 protein by DNA injection. In Vaccines '93: Modern Approaches to New Vaccines Including Prevention of AIDS. H. Ginsberg et al., Eds.: 137–141. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, New York . 75 Wang, B., K. E. Ugen, V. Srikantan, M. G. Agadjanyan, K. Deng, W. V. Williams & D. B. Weiner. 1993. Genetic immunization: A novel method for vaccine development against HIV. In Vaccines '93: Modern Approaches to New Vaccines Including Prevention of AIDS. H. Ginsberg et al., Eds.: 143–150. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, New York . 76 Clerici, M., J. V. Giorgi, C.-C. Chou, V. K. Gudeman, J. A. Zack, P. Gupta, H.- N. Ho, P. G. Nishanian, J. A. Berzofsky & G. M. Shearer. 1992. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J. Infect. Dis. 165: 1012–1019. 77 Kelker, H. C., M. Seidlin, M. Vogler & F. T. Valentine. 1992. Lymphocytes from some long-term seronegative heterosexual partners of HIV-infected individuals proliferate in response to HIV antigens. AIDS Res. Human Retroviruses 8: 1355–1359. 78 Siliciano, R. F., R. C. Bollinger, K. M. Callahan, S. A. Hammond, A. Y. Liu, E. P. Miskovsky, J. P. Rowell & P. E. Stanhope. 1992. Clonal analysis of T-cell responses to the HIV-1 envelope proteins in AIDS vaccine recipients. AIDS Res. Human Retroviruses 8: 1349–1352. Citing Literature Volume685, Issue1Immunomodulating DrugsJune 1993Pages 697-712 ReferencesRelatedInformation" @default.
• W2046504744 created "2016-06-24" @default.
• W2046504744 creator A5042379354 @default.
• W2046504744 creator A5073264142 @default.
• W2046504744 date "1993-06-01" @default.
• W2046504744 modified "2023-09-25" @default.
• W2046504744 title "Gene Transfer for Therapy and Prophylaxis of HIV-1 Infection" @default.
• W2046504744 cites W1233534743 @default.
• W2046504744 cites W1415981329 @default.
• W2046504744 cites W1554330891 @default.
• W2046504744 cites W1570375907 @default.
• W2046504744 cites W1572649493 @default.
• W2046504744 cites W1699538093 @default.
• W2046504744 cites W1766215719 @default.
• W2046504744 cites W1895087506 @default.
• W2046504744 cites W1939899968 @default.
• W2046504744 cites W1964620549 @default.
• W2046504744 cites W1965164228 @default.
• W2046504744 cites W1966434125 @default.
• W2046504744 cites W1973035870 @default.
• W2046504744 cites W1973630161 @default.
• W2046504744 cites W1976562259 @default.
• W2046504744 cites W1976579475 @default.
• W2046504744 cites W1977453669 @default.
• W2046504744 cites W1981457569 @default.
• W2046504744 cites W1985337349 @default.
• W2046504744 cites W1992683016 @default.
• W2046504744 cites W1996366091 @default.
• W2046504744 cites W1999200731 @default.
• W2046504744 cites W2000070726 @default.
• W2046504744 cites W2001332902 @default.
• W2046504744 cites W2006097442 @default.
• W2046504744 cites W2006710343 @default.
• W2046504744 cites W2008266730 @default.
• W2046504744 cites W2014495927 @default.
• W2046504744 cites W2016138321 @default.
• W2046504744 cites W2023700464 @default.
• W2046504744 cites W2024729580 @default.
• W2046504744 cites W2026855844 @default.
• W2046504744 cites W2027853697 @default.
• W2046504744 cites W2027982069 @default.
• W2046504744 cites W2028592334 @default.
• W2046504744 cites W2035840423 @default.
• W2046504744 cites W2045224288 @default.
• W2046504744 cites W2049071996 @default.
• W2046504744 cites W2050992506 @default.
• W2046504744 cites W2051103078 @default.
• W2046504744 cites W2056877436 @default.
• W2046504744 cites W2058319782 @default.
• W2046504744 cites W2059015795 @default.
• W2046504744 cites W2081195281 @default.
• W2046504744 cites W2083787054 @default.
• W2046504744 cites W2084208256 @default.
• W2046504744 cites W2087625688 @default.
• W2046504744 cites W2087791213 @default.
• W2046504744 cites W2091994827 @default.
• W2046504744 cites W2098393725 @default.
• W2046504744 cites W2110393059 @default.
• W2046504744 cites W2110582366 @default.
• W2046504744 cites W2117460367 @default.
• W2046504744 cites W2119125001 @default.
• W2046504744 cites W2128398347 @default.
• W2046504744 cites W2128622060 @default.
• W2046504744 cites W2129859001 @default.
• W2046504744 cites W2130397278 @default.
• W2046504744 cites W2143329914 @default.
• W2046504744 cites W2154633957 @default.
• W2046504744 cites W2315735240 @default.
• W2046504744 cites W2319534054 @default.
• W2046504744 cites W2329135993 @default.
• W2046504744 cites W2331183830 @default.
• W2046504744 cites W2412001365 @default.
• W2046504744 cites W2461163283 @default.
• W2046504744 doi "https://doi.org/10.1111/j.1749-6632.1993.tb35933.x" @default.
• W2046504744 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8363276" @default.
• W2046504744 hasPublicationYear "1993" @default.
• W2046504744 type Work @default.
• W2046504744 sameAs 2046504744 @default.
• W2046504744 citedByCount "2" @default.
• W2046504744 crossrefType "journal-article" @default.
• W2046504744 hasAuthorship W2046504744A5042379354 @default.
• W2046504744 hasAuthorship W2046504744A5073264142 @default.
• W2046504744 hasConcept C104317684 @default.
• W2046504744 hasConcept C111599444 @default.
• W2046504744 hasConcept C159047783 @default.
• W2046504744 hasConcept C177713679 @default.
• W2046504744 hasConcept C203014093 @default.
• W2046504744 hasConcept C3013748606 @default.
• W2046504744 hasConcept C3018928802 @default.
• W2046504744 hasConcept C54355233 @default.
• W2046504744 hasConcept C71924100 @default.
• W2046504744 hasConcept C86803240 @default.
• W2046504744 hasConceptScore W2046504744C104317684 @default.
• W2046504744 hasConceptScore W2046504744C111599444 @default.
• W2046504744 hasConceptScore W2046504744C159047783 @default.
• W2046504744 hasConceptScore W2046504744C177713679 @default.
• W2046504744 hasConceptScore W2046504744C203014093 @default.
• W2046504744 hasConceptScore W2046504744C3013748606 @default.

• next